Direkt zum Inhalt
Merck

[Vasobral in the treatment of brain lesions: views of physicians and patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2013-03-27)
P R Kamchatnov
ZUSAMMENFASSUNG

A study was based on the survey of 419 neurologists and 1189 their patients with different forms of cerebrovascular diseases using a specially developed questionnaire. In most cases, vasobral was used as a monotherapy or in a complex treatment. Twenty-two percent of physicians reported that vasobral was the most effective compared to other drugs. The good tolerability of treatment (18%) and the broad spectrum of indications and clinical effects (17%) were reported as well. The large percentage (75%) of patients indicated the positive effect of vasobral on memory, reasoning, vertigo etc The maximal effect was identified in the treatment of mild cognitive impairment caused by chronic brain ischemia and vertebrobasilar insufficiency. Vasobral is recommended for a use in a complex therapy in patients with more severe brain lesions and cognitive deficit.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Koffein, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Coffein Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Koffein -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Koffein, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Koffein, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Koffein, meets USP testing specifications, anhydrous
Supelco
Koffein -Lösung, analytical standard, 1.0 mg/mL in methanol
Supelco
Mettler Toledo Calibration Substance ME 18872, Caffeine, traceable to primary standards (LGC)
Sigma-Aldrich
Koffein, anhydrous, tested according to Ph. Eur.
Koffein für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Koffein, BioXtra
Koffein, European Pharmacopoeia (EP) Reference Standard